Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aligo Venture Capital is a Poland-based venture capital fund focused on early-stage investments. The firm typically invests between €200K and €500K, often as a sole investor or in co-financing rounds. Their portfolio includes companies addressing global health and environmental challenges.
Aligo Venture Capital invests in early-stage healthtech and cleantech companies, primarily at the pre-seed and seed stages. The fund's check sizes range from €200K to €500K, targeting innovations that leverage technology for health improvements and environmental sustainability.
Notable portfolio companies include Dietary Supplements, focused on dermatological problems; Digital Therapeutics, designed for cancer patients; and a SaaS Platform that helps organizations manage their carbon footprint. Other investments include Britescope, a portable video-nasopharyngoscope for ENT diagnostics, and PredictWatch, which uses A.I. for relapse prediction in addiction.
As of the latest update, Aligo Venture Capital has been active in the ecosystem, recently discussing the exit of Wellbeing Polska from their portfolio, indicating ongoing engagement with their investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.